Daily Stock List
TMM, Inc. (TMMI)
PennyStocks24 reported earlier this month on TMM, Inc. (TMMI), SmallCapVoice did previously, and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
TMM, Inc. owns outright, VDK SoftVideo fractal compression technology that utilizes fractal video compression and decompression algorithms originally licensed from Iterated System, Inc. The Company is integrating this technology with their TRUDEF™ portfolio of products. TRUDEF™ is the successor of the Company's VDK SoftVideo™ fractal compression products developed in the 1990s. TMM is based Wilmington, Delaware.
TRUDEF™ is under development to meet the demands of the growing high definition (HD) video market. Fractal compression has the ability to decompress images into larger resolutions than the original - while maintaining a high level of image quality. TMM develops digital video compression technology that provides end-to-end workflow and distribution solutions for cinema, sports, mobile, streaming media, cable, medical imaging, security, defense, space exploration and education.
The Company's TRUDEF™ fractal technology offers users enhanced image quality, reduced bandwidth utilization, and digital media storage requirements. TMM's immediate objective is to complete the modernization of their TRUDEF™ technology and to incorporate TRUDEF™ into an assortment of commercial products to meet the demands of the exponentially expanding HD video market.
A vital feature of the multi threaded TRUDEF™ Player is its ability to play highly detailed 2x2 block encoded 24 bit RGB color video scaled from 2K to 4K resolution in real time. TRUDEF™ resolution independent fractal codes are calculated during compression on the "original pixels".
TMM's products also include TRUDEF™ Playlist Editor (Version 1.1_000). The TRUDEF™ Playlist Editor manages multiple playlists; offers drag and drop list building; offers a draggable sort order, and allows for timeline cropping. Furthermore, the Company has their TRUDEF™ Fractal Video Compressor. TRUDEF™ compresses video in the 24 bit RGB/YUV 4:4:4 color space; this offers a rich viewing experience.
At the beginning of this month, TMM announced the appointment of Mr. Louis H. Siracusano, Jr. to the Company's Advisory Board, effective May 1, 2013. Mr. Siracusano Jr. is the President/CEO and founder of VideoBank. VideoBank is an industry leader in digital video solutions for private enterprise and the United States military.
TMM, Inc. (TMMI), closed Tuesday's trading session at $0.122, down 12.23%, on 44,525 volume with 7 trades. The average volume for the last 60 days is 96,960 and the stock's 52-week low/high is $0.055/$0.30.
MMRGlobal, Inc. (MMRF)
PennyStocks24 reported last week on MMRGlobal, Inc. (MMRF), HyperSpeedStocks, OtcWizard, Wallstreetlivechat, MoneyTV, FeedBlitz did earlier, and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.
MMRGlobal, Inc., through their wholly owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records (PHRs) and MyEsafeDepositBox storage solutions. They also provide electronic document management and imaging systems for healthcare professionals. The Company serves consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups.
Their MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents anytime from anywhere using the Internet. The building of MyMedicalRecords is on proprietary, patented technologies to allow documents, images and voicemail messages to undergo transmission and storage in the system using an assortment of methods, including fax, phone, or file upload without relying on any particular electronic medical record platform to populate a user's account.
MMRGlobal's professional offering is MMRPro. The design of MMRPro is to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients by way of an integrated patient portal. Through their merger with Favrille, Inc. in January of 2009, MMRGlobal acquired intellectual property (IP) biotech assets that include anti-CD20 antibodies and data and samples from their FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma.
MMRGlobal has an extensive healthcare IT patent portfolio; it includes seven U.S. patents. The MMR Patent Portfolio also includes almost 400 claims, additional applications, and continuation applications. The patents involve inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. The Company has been granted patents and has other pending applications in countries of commercial interest including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, South Korea, Israel, and European nations.
Last week, MMRGlobal announced that their primary business would be expanded from their previous focus of selling consumer and professional products and services, to equally exploiting and licensing their health information technology patents domestically and globally.
Additionally, last week, MMRGlobal announced the addition of two new members to their Medical Board of Advisors. One is Dr. Cara Natterson, M.D., a Board-Certified Pediatrician, consultant and The New York Times best-selling author on child health and parenting. The other is Dr. Jeremy Fine, M.D., a Concierge Medicine Specialist and Board-Certified in Internal Medicine.
MMRGlobal, Inc. (MMRF), closed Tuesday's trading session at $0.0625, down 2.34%, on 439,976 volume with 25 trades. The average volume for the last 60 days is 1,443,979 and the stock's 52-week low/high is $0.0111/$0.125.
LifeTech Industries, Inc. (LTCH)
PenniesPicks reported earlier on LifeTech Industries, Inc. (LTCH), and we report on the Company today, here at the QualityStocks Daily Newsletter.
LifeTech Industries, Inc. engages in the business of air to water generator distribution and technology licensing. Their business plan is to market and distribute AirWell air to water generation systems and license the technology and corresponding distribution rights to third parties around the world. LifeTech Industries has their headquarters in Palo Alto, California.
LifeTech Industries entered into a Joint Venture (JV) Agreement, a Distribution Agreement, and a Technology License Agreement with LifeTech Japan Corp., a Japanese corporation. LifeTech acquired the worldwide exclusive right (excluding Japan) to make, use, sell or otherwise distribute LifeTech Japan's atmospheric water generator (AWG) products and technologies.
LifeTech Japan also granted LifeTech Industries an exclusive and perpetual license to any and all of their patents, trademarks and all other intellectual property (IP) related to LifeTech Japan's AWG products, and the worldwide exclusive right (excluding Japan) to assign, sublicense or otherwise transfer such rights in LifeTech Japan's technology to third parties, globally. All product design, production, and research and development is performed and managed by the Company's strategic partner, LifeTech Japan.
In November 2012, LifeTech announced that they launched the advanced atmospheric water generator: AirWell Water Systems. Their AirWell System is a highly advanced atmospheric water generator (AWG). It produces healthy drinking water through promoting and filtering the condensation of moisture from air. The AirWell method uses an advanced triple-step gathering system and a 12-step purification process to produce water that is free of chemicals, pollutants, contaminants and hormones.
The Company's manufacturer currently produces a home/office unit that generates approximately 30 liters of water daily. LifeTech's air to water generation and filtration technology is scalable; the Company is currently in the process of developing customizable units to service the water needs of an assortment of industries. These include shipping and boating; hotels and resorts; hospitals and schools; mining and drilling; government and military; spas and "well-being" facilities, and humanitarian organizations.
LifeTech Industries' air to water generation and filtration technology is currently patented in Taiwan and Japan. In December 2012, LifeTech Industries signed an exclusive ten-country distribution agreement with SunPlex Ltd. LifeTech and SunPlex agreed to a five-year distribution plan.
LifeTech Industries, Inc. (LTCH), closed Tuesday's trading session at $0.125, up 19.05%, on 1,100 volume with 2 trades. The average volume for the last 60 days is 50,368 and the stock's 52-week low/high is $0.048/$1.15.
Dolat Ventures, Inc. (DOLV)
Real Pennies reported recently on Dolat Ventures, Inc. (DOLV), StockMister, Stockhunter.us, Stock Brain, VIP STOCK ALERTS, HEROSTOCKS, Liquid Pennies, USA Market News, PennyStockShark, Winning Penny Stock Picks, PennyStockPickAlert, PennyStockMoneyTrain, Liquid Tycoon did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Dolat Ventures, Inc., via their wholly and majority owned subsidiaries, Dove Diamonds and Mining, Inc. and Millennium Mining, LLC, respectively, is focusing on the early stages of acquiring diamonds, gems and precious stones from various locations throughout the African continent. Incorporated in 2006, the Company is an exploration stage enterprise. Dolat Ventures' shares trade on the OTC Markets' OTCQB. The Company has their corporate headquarters in New York, New York.
On December 15, 2009, they acquired 100 percent of the outstanding capital stock of Dove Diamonds and Mining, a Nevada Corporation. On April 13, 2010, Dolat Ventures entered into a Share Exchange Agreement under which they agreed to exchange 30,000,000 shares of Common stock to Millennium Mining in exchange for 75 percent, or 22,500,000 shares of the issued and outstanding capital stock of Millennium.
Dolat Ventures mines Baimbawai Pool, which is an area of the Sewa River situated in the Tinkonko Chiefdom in the southern part of Sierra Leone. The Sewa River is an internationally known alluvial diamond river that has produced gem class quality diamonds. The Company sells their diamonds in Sierra Leone and around the world. Sierra Leone has been a major diamond producer for 70 years.
Individuals from two villages own the Baimbawai pool. These villages are Gandorhun and Njala, located on either side of the river. On January 26, 2008, these five individuals entered into an agreement with Dove Diamonds allowing the Company to dredge, mine and explore this land.
The Company's Dove Diamonds and Mining is in an organized search for mineral locations, suppliers and sellers of diamonds, gems and precious stones. Dove intends to acquire equipment, mining operations and mining locations, and to establish distribution channels to sell their diamonds to wholesalers and retailers in the U.S. and globally. Dove currently has no plans to sell directly to consumers.
Millennium Mining's core operations are to mine, extract, refine, and purify precious metals and stones. Their intention is to buy, sell, distribute and export diamond bauxite, rutile gold, silver and all other precious minerals in Sierra Leone and worldwide.
Dolat Ventures, Inc. (DOLV), closed Tuesday's trading session at $0.007, up 55.56%, on 3,395,392 volume with 17 trades. The average volume for the last 60 days is 127,151 and the stock's 52-week low/high is $0.0044/$0.25.
Temex Resources Corp. (TME.V)
Today we are highlighting Temex Resources Corp. (TME.V), here at the QualityStocks Daily Newsletter.
Based in Toronto, Ontario, Temex Resources Corp. is an exploration company concentrating on their portfolio of precious metals properties in northeastern Ontario. The Company has an Ontario, NI 43-101 Resource Base. Temex is exploring the Timmins Whitney Property (60 percent), in partnership with Goldcorp (40 percent), and exploring their Juby Gold Project (100 percent Temex Resources).
Their Whitney Gold Project is an advanced gold project. It includes 4 km of the prolific Timmins gold trend. The Whitney property contains a number of near-surface gold targets. These include the Upper Broulan Reef Zone, C Zone, and Q Zone. The Whitney Property has open pit and underground NI 43-101 compliant resources on the Upper Hallnor of 3.0 million tonnes at a grade of 2.44 g/t gold for 234,300 ounces of gold in the Measured category plus 8.8 million tonnes at a grade of 1.97 g/t gold for 555,900 ounces of gold in the Indicated category. It also has 4.1 million tonnes at a grade of 1.82 g/t gold for 241,000 ounces of gold in the Inferred category at a cut-off grade of 0.30 g/t gold for open pit and 2.0 g/t for underground.
The Juby Main Zone has NI 43-101 compliant resources of 25.3 million tonnes at a grade of 1.28 g/t gold for 1,041,343 ounces of gold in the Indicated category and 74.2 million tonnes at a grade of 0.91 g/t gold for 2,174,193 ounces of gold in the Inferred category. These are both at a cut-off grade of 0.40 g/t gold.
In addition, Temex has an NI 43-101 compliant resource for tailings material on their Gowganda Silver Project. The tailings piles contain an NI 43-101 compliant resource of 1.94 million tonnes grading 47.5 g/t silver for a contained resource of 2.96 million ounces of silver in the Indicated category. The Gowganda Silver Property is 533 acres (100 percent Temex). Furthermore, Temex has their Latchford Gold Project. It consists of the Brett - Rib Lake Block: 100 percent Temex, 11,480 acres; the Merico Ethel Property: 100 percent Temex, 3,920 acres; the Yarrow Property: 100 percent Temex 1,080 acres, and the Mattawapika Property: 100 percent Temex, 1,120 acres.
Last month, Temex Resources announced an updated National Instrument 43-101 (NI 43-101) resource estimate on the Juby Gold Project. They also announced the assay results of the final four holes drilled in the resource area during the 2012-2013 exploration campaign. The drill campaign focused on expanding the inferred resource. This increased by 140 percent to 2.2 million ounces of gold at a 0.4 g/t cut-off (74.2 million tonnes at 0.91 g/t gold) in comparison to the previous estimate published in January 2012 and within which the Core Zone contains 1,059,939 ounces within 21,502,000 tonnes at a weighted average grade of 1.53 g/t gold. The indicated resource increased by 11 percent to 1.04 million ounces (25.3 million tonnes at 1.28 g/t gold) versus the prior estimate.
Temex Resources Corp. (TME.V), closed Tuesday's trading session at $0.135, up 3.85%, on 316,000 volume. The stock's 52-week low/high is $0.10/$0.36.
Otis Gold Corp. (OOO.V)
Streetwise Reports and Vantage Wire reported previously on Otis Gold Corp. (OOO.V), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the TSX Venture Exchange, Otis Gold Corp. is a resource company with corporate headquarters in Vancouver, British Columbia. The Company is focusing on the acquisition, exploration, and development of precious metal deposits in the State of Idaho. Currently, Otis is developing their flagship property, the Kilgore Gold Project, in Clark County, Idaho. Otis Gold is concentrating on developing projects that have multi-million ounce potential located in mining-friendly jurisdictions.
The Kilgore Gold Deposit contains an NI 43-101 Indicated Resource of 520,000 oz Au in 27.4 million tonnes at a grade of 0.59 g/t Au and an Inferred Resource of 300,000 oz Au in 20.2 million tonnes at a grade of 0.46 g/t Au. The deposit comprises the continuous and contiguous Prospect Ridge, Mine Ridge and North Target areas.
The Company's Oakley Gold Project consists of 107 federal lode mining claims and a number of Utah State leases (consisting of 1,360 acres) situated in Cassia County, Idaho. This is approximately 15 miles south of the town of Oakley and just north of the Utah/Nevada border. Their Hai Property consists of 7 located lode claims covering historical gold workings called the Little Chief Extension in the Lemhi Counties of Idaho. Otis Gold's Gold Bug property is approximately three miles from the Hai property and consists of nine lode claims.
At the beginning of May, Otis Gold announced that their proposed joint venture allowing Lateral Gold Corp. to earn up to a 100 percent interest in the Oakley Gold Project over a 7.5-year period was approved by the TSX-V. The Company has received the initial cash and share payments.
Additionally, concerning the Kilgore Gold Project, Otis has submitted a Plan of Operations to the Caribou-Targhee National Forest. This is to build approximately 1,550 meters of roads into the North Target Area, located immediately next to the existing Kilgore Gold Deposit and in a region that has recently achieved very strong drilling results. This includes (82.3 meters (m) of 0.95 grams per tonne gold (g/t Au) in hole 12 OKR-291, 121.9 m of 1.04 g/t Au, that includes 45.7 m of 1.52 g/t Au, in hole 12 OKR-292, and 83.8 m of 1.12 g/t Au, which includes 30.5 m of 2.10 g/t Au, in hole 12 OKR-294.
Otis Gold Corp. (OOO.V), closed Tuesday's trading session at $0.07, up 16.67%, on 25,000 volume. The stock's 52-week low/high is $0.06/$0.25.
PURE Bioscience, Inc. (PURE)
MissionIR, SmarTrend Newsletters, Investor News Source, Tiny Gems, and Greenbackers reported earlier on PURE Bioscience, Inc. (PURE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
PURE Bioscience, Inc. is the creator of the patented silver dihydrogen citrate (SDC) antimicrobial. The Company develops and markets technology-based bioscience products that provide solutions to many global health challenges. These include Staph (MRSA) and Carbapenem-resistant Enterobacteriaceae (CRE)/NDM-1+. PURE Bioscience has their headquarters in El Cajon, California. Incorporated in 1992, the Company lists on the OTCQB.
PURE Bioscience's proprietary high efficacy/low toxicity bioscience technologies (including their silver dihydrogen citrate-based antimicrobials) represent unique advances in different markets and lead today's global trend toward industry and consumer use of "green" products. This is while providing competitive advantages in efficacy and safety.
The aforementioned Patented SDC is an electrolytically generated source of stabilized ionic silver; it formulates well with other compounds. PURE's patented SDC is the first new antimicrobial in decades. SDC can serve as the basis for a broad spectrum of products in different markets. It is colorless, odorless, tasteless and non-caustic. PURE Bioscience produces and markets pre-formulated, ready-to-use product, and varying strengths of SDC concentrate as an additive or raw material for inclusion in other products.
Last week, PURE Bioscience announced that the Company appointed food industry leader Mr. Dave Pfanzelter as Chairman of the Board. Mr. Pfanzelter has been a member of the Board since February 2013. He had previously served on the PURE Bioscience Advisory Panel. He previously served as Senior Vice President of Kellogg Company, President of Kellogg's Specialty Channels, and President of Kellogg Canada while also serving as part of the Kellogg Executive Committee and Global Leadership Team.
PURE's products include SDC-Based Hard Surface Disinfectant. SDC is the basis for the EPA registered hard surface disinfectant, PURE Hard Surface. SDC is highly toxic to bacteria, fungus and virus; it is non-toxic to humans and animals. SDC kills microorganisms via two modes of action. The silver ion deactivates structural and metabolic membrane proteins leading to microbial death. In addition, the microbes view SDC as a food source, allowing the silver ion to enter the microbe. Once inside the organism, the silver ion denatures the DNA. This halts the microbe's ability to replicate and leads to its death.
PURE Bioscience, Inc. (PURE), closed Tuesday's trading session at $0.44, up 46.67%, on 318,847 volume with 100 trades. The average volume for the last 60 days is 8,958 and the stock's 52-week low/high is $0.2203/$0.40.
Titan Medical, Inc. (TITXF)
MadPennyStocks, CoolPennyStocks, BullRally, PennyStockVille, HotOTC, StockRich, and Sharemkt Tips reported previously on Titan Medical, Inc. (TITXF), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Titan Medical, Inc. focuses on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS). The design of the robotic surgical system is to expand robotic surgery into areas of surgical specialties and simple and complex procedures that are presently under-serviced. The design of it is also to allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. Listed on the OTCQX International, Titan Medical has their headquarters in Toronto, Ontario.
Currently under development, Titan's robotic surgical system consists of a surgeon-controlled robotic platform, which includes a 3D vision system and interactive instruments for performing MIS procedures. It additionally includes a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The Company now has seven granted patents and ten patent applications.
In early May, Titan Medical announced that they completed prototyping of their 3D HD chip-on-tip camera system to be used in the Company's Single Incision surgery system. The innovative chip-on-tip technology will be an important part of the system. It will allow surgeons the flexibility and capability for viewing with a single incision approach. The Company is advancing the development of their Single Incision Surgery system; they remain on track to commercialization.
Last week, the Company announced their results for the three months ended March 31, 2013. Selected financial highlights include a net loss for the three months ended March 31, 2013 of $2,462,727. This is in comparison to a net loss of $3,327,534 for the three months ended March 31, 2012. The decrease was attributable to a shift from a focus on the development of a multi-port platform to a focus on the development of a single incision platform. The Company's cash and cash equivalents at March 31, 2013 totaled $8,563,033, versus $4,617,016 at December 31, 2012.
Titan Medical, Inc. (TITXF), closed Tuesday's trading session at $0.55, down 2.65%, on 142,318 volume with 34 trades. The average volume for the last 60 days is 166,793 and the stock's 52-week low/high is $0.43/$1.54.
X-Change Corp. (XCHC)
The QualityStocks Daily Newsletter would like to spotlight X-Change Corp. (XCHC). Today, The Aristocrat Group Corp. closed trading at $0.051, off by 3.77%, on 418,599 volume with 34 trades. The stock’s average daily volume over the past 60 days is 527,529, and its 52-week low/high is $0.025/$0.25.
X-Change Corp. was pleased to issue a positive market update today amid constant signs of progress from states and countries regarding their cannabinoid laws, with strong public support opening the door for cannabinoid formulation-based health solution developers like XCHC. Citing the historic pick-up in March of this year across the U.S. which spilled over well into April, with 30 states in some form of legalization or decriminalization progress, today's report provides a litany of recent legislative milestones on the issue, as well as a closer look at how market expansion dovetails with the Patient Resource Center on the upgraded Phytiva.com website.
X-Change Corp. (XCHC) specializes in cannabinoid based extracts and products that target medical cannabis, nutraceutical, cosmeceutical, and social usage solutions through multiple Phytiva brand product lines, products, and services. The company plans to launch a combination of retail and wholesale products, medical cannabis dispensaries, cannabis research in clinics and laboratories, and other legal state and foreign operations.
The company’s Phytiva brand utilizes the unique and potent benefits of cannabinoids, the natural components found in the cannabis sativa L. plant, from which cannabis and hemp are produced. The company’s formulations target not just the symptom, but the cause of critical ailments. Because the body responds extremely well to their properties, X-Change believes cannabinoids provide the ideal solution for better treatment and patient outcomes.
Respect for human life is a core value of the Phytiva brand, and X-Change believes that there are countless possibilities to be unleashed from the cornucopia of nature for good health and wellbeing. Phytiva uses the latest science and technology to study these possibilities with a key focus on making its carefully developed solutions accessible to all. First, all of Europe, the United States, and then beyond.
The staggering numbers of cases of HIV/AIDS, cancer, autoimmune disease, MRSA, diabetes, and a number of other ailments is X-Change’s motivation to bring superior products to their respective markets, but the company is also targeting opportunities in the $350 billion personal care market. Leveraging its unique formulations and the branding abilities of its team, X-Change is well positioned to provide cannabinoid-based solutions to the mainstream market through multiple avenues. Disclaimer
X-Change Corp. Company Blog
X-Change Corp. News:
X-Change Corporation Issues Positive Market Update and Reinforces Existing Outlook Upon Seeing Momentum for Support and Industry Changes
The X-Change Corporation Continues New Product Development Progress Simultaneously with European Line and Extract-Based Products
X-Change Corporation Launches Upgraded Version of Phytiva Website, As Company Targets Distribution of Phytiva Product Line in United States and Worldwide, Extracts and New Products in Europe
Rainbow Coral Corp. (RBCC)
The QualityStocks Daily Newsletter would like to spotlight Rainbow Coral Corp. (RBCC). Today, Rainbow Coral Corp. closed trading at $0.28, up 7.69%, on 155,075 volume with 54 trades. The stock’s average daily volume over the past 60 days is 280,199, and its 52-week low/high is $0.10/$2.67.
Rainbow Coral Corp. reported today that they have opening talks to potentially partner with an emerging innovator in the transdermal delivery sector to help carve out a larger slice of the burgeoning $142B U.S. drug delivery market, where transdermal patches have become a wildly popular system thanks to the robust advantages over oral and intravenous methods. With forecasts for the transdermal delivery market coming in around $31.5B by 2015 alone, this move by RBCC to partner with a rapidly emerging leader in the space is a shrewd maneuver to capture significant market share from that growth.
Rainbow Coral Corp. (RBCC), via wholly owned subsidiary Rainbow Biosciences, continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. The company specifically pursues opportunities that offer short-term marketability and commercialization potential in key areas like Alzheimer's, Parkinson's, and Cancer.
Bioscience technology is a growing, dynamic field of innovation that applies life processes to practical uses, such as the manufacturing of medical devices and the development of new bioscience procedures. From pharmaceuticals to pacemakers, genetically engineered plants to gene therapy, bioscience technology can be found virtually anywhere.
The pending joint venture with Amarantus BioScience to develop and market new therapies and treatments for neurological diseases and physical traumas is a great example of the initiatives underway. In recent news, Amarantus licensed a highly promising diagnostic blood test that could become an invaluable new tool in Alzheimer's clinical trials where patient recruitment errors occur often due to inaccurate diagnosis.
The global biotech industry, currently valued at more than $84.6B, allows new players with bright ideas to quickly grab market share and create completely new markets. The exciting initiatives being driven forward by Rainbow Coral promise to transition today's leading-edge research into practical, affordable treatments for people who need them most. Disclaimer
Rainbow Coral Corp. Company Blog
Rainbow Coral Corp. News:
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
RBCC Partner n3D Signs U.S. Distribution Agreement
World’s Premiere Science Journal Touts Revolutionary Innovations by RBCC Partner Nano3D
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.0154, up 4.76%, on 829,609 volume with 10 trades. The stock’s average daily volume over the past 60 days is 611,263, and its 52-week low/high is $0.0158/$0.0013.
Viaspace Inc. announced today that the company's CEO, Dr. Carl Kukkonen, has returned from Nicaragua where a series of business meetings ultimately culminated in the signing of a Joint Development Agreement with Grain Hill/AGRICORP that will established a special purpose company for the creation and running of a 2.1k-acre Giant King™ Grass plantation and a co-located 12 MW biomass power plant. The agreement, signed by CEO's of both companies, looks to create the facility at an ideal site for the biomass wonder's propagation, on the shores of Lake Nicaragua, at AGRICORP's Agricola Miramontes plantation.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE and AGRICORP Sign Joint Development Agreement for 12 MW Power Plant Co-located with 2,100 acre Giant King Grass Plantation in Nicaragua
VIASPACE's Giant King Grass to Biogas for Electricity Paper Presented at International Biomass Conference
VIASPACE 7 MW Power Purchase Agreement Nearly Finalized in St. Croix, Giant King Grass Growing Well
The Guitammer Company Inc. (GTMM)
The QualityStocks Daily Newsletter would like to spotlight The Guitammer Company Inc. (GTMM). Today, The Guitammer Company Inc. closed trading at $0.18, even with yesterday's close. The stock’s average daily volume over the past 60 days is 12,338, and its 52-week low/high is $0.082/$0.35.
The Guitammer Company Inc. announced entry today into a promotional partnership with Warner Bros. Pictures and Legendary Pictures, for this summer's release from acclaimed filmmaker Guillermo del Toro - "Warner Bros. Pictures and Legendary Pictures Pacific Rim." Thus marking the fourth partnering between GTMM and Warner Bros. to tap those key 18 - 35 and the 25 - 54 demographics in a compelling and fun way that fully engages ButtKicker®-brand low frequency audio transducer customers.
The Guitammer Company Inc. (GTMM) is a leader in low frequency sound products and technology. Its innovative and award winning line of patented ButtKicker-brand low frequency audio transducers let users feel low-frequency sound (bass). ButtKicker brand products are used around the world by leading entertainment and theater companies such as AMC, IMAX and Disney in movie theaters and attractions; by world-famous musicians; in home theaters, simulators and for car audio.
ButtKicker brand products are distributed by Pearl Drums for musicians under the trade name, "Pearl's Throne Thumper by ButtKicker", and factory installed in home theater seating by Palliser Furniture. ButtKicker brand products' patented design makes them musically accurate, powerful and virtually indestructible. The Company is headquartered in Westerville, OH.
The Guitammer Company's newly patented broadcast technology, ButtKicker LIVE! enables the excitement, impact and feeling of sporting events to be broadcast along with the sound and video. ButtKicker LIVE! puts you into the action, whether you're at home or at the event.
ButtKicker Live! technology is available for cable, satellite, fiber optic, IPTV and over-the-air broadcast and has been successfully tested with several major content (sports) providers. ButtKicker(r) and ButtKicker Live!(r) are registered trademarks of The Guitammer Company. Disclaimer
The Guitammer Company Inc. Company Blog
The Guitammer Company Inc. News:
Warner Bros., Legendary Pictures, and Guitammer Team Up for Summer Release of "Pacific Rim," From Oscar®-Nominated Director, Guillermo del Toro
The Guitammer Company Announces First Quarter 2013 Results
Guitammer and Digiplex Join Forces to Offer "4D Powered by ButtKicker(R)" to Movie Goers
X-Change, a company specializing in cannabinoid based extracts and products that target medical cannabis, nutraceutical, cosmeceutical, and social usage solutions, today issued a positive market update as many states and countries make progress in their cannabinoid laws, and public support continues to grow.
The historic legislative pick-up in March of this year occurred all over the United States, which now has over 30 states with some form of legalization or decriminalization progress. This momentum continued in April with the release of a national poll favoring legalization. The momentum continued just last week with an announcement coming out of Australia where a unanimous recommendation was made by a parliamentary committee, which if adopted would allow patients to use up to 15 grams of dry cannabis or its equivalent in cannabis products. There are approximately 17 countries that have some kind of decriminalization or legalization legislation.
“This progress opens up many markets for our products and our research in the US, Europe, and abroad. The EU markets expansion is a benefit for X-Change, and we are doing the final preparations on releasing the EU product line of extracts. The progress we see in the United States is expanding our US market base for our over the counter personal care products also in final preparations for being released. This market expansion has aligned properly with the release of the Patient Resource Center on the upgraded Phytiva.com website, which will allow people to connect in an open manner that allows them to make progress along side of ours,” stated Robert Kane, President & CEO of X-Change Corporation.
The poll showed a majority of adult Americans support legalization, 52%, according to the survey released by the Pew Research Center. Further, 72% to 23% of respondents said the federal government’s efforts against marijuana “cost more than they are worth.” By nearly 2-to-1, respondents said the federal government should not enforce its anti-cannabis laws in states that allow use of the drug.
This news supports all the progress made across the United States. A synopsis of this news follows:
A Colorado Senate Sub Committee voted unanimously to pass SB13-241. The bill, sponsored by state Sen. Gail Schwartz, D-Snowmass Village, would enable farmers to register for 10-acre research-and-development plots to test the viability of different hemp varieties. Advocates say hemp is poised to become a big industry in Colorado.
In Maine, cannabis legalization was formally introduced with 35 co-sponsors. LD 1229 is “An Act to Tax and Regulate Marijuana” and, would allow the sale of as much as 2 ½ ounces of cannabis per week to people 21 and older at licensed retail locations. It would also permit the cultivation of the cannabis plant in private settings. This would make Maine the third state to legalize the adult consumption of cannabis and regulate its retail production and sale, following Colorado and Washington State.
Kentucky took a bold stand on hemp legislation in March and passed an amended version of Senate Bill 50, “An Act relating to industrial hemp.” Senate Bill 50 “establishes conditions and procedures for the licensing of industrial hemp growers by the Department of Agriculture.” The Kentucky Industrial Hemp Commission will work with the state Department of Agriculture, and the University of Kentucky Agricultural Experimental Station will engage in research related to hemp production. The bill passed the House by a vote of 88 to 4. The Senate re-approved the measure by a vote of 35 to 1.
A medical cannabis measure cleared the House of Delegates in Maryland in late March. The measure moves on to the Senate, who voted in favor of an initiative to decriminalize the possession of small amounts of cannabis.
In New York, Assembly Bill 6357 and Senate Bill 4406 were introduced as joint legislation to legalize medical cannabis under a tightly regulated system. The legislation was passed by a vote of 21-4.
On March 28th, West Virginia held a hearing on HB 2961, which would legalize medical cannabis and allow up to five dispensaries to open in the state. Lawmakers have also introduced bills in Nevada and Oregon to legalize medical cannabis dispensaries.
Supporters in Alaska have submitted a petition to get a measure on the 2014 ballot to legalize, regulate, and tax cannabis. Alabama’s State Rep. Patricia Todd (D-Birmingham) introduced the Alabama Cannabis and Hemp Reform Act of 2013, which would allow the personal and medical use of cannabis as well as legalize and regulate the production of industrial hemp. Illinois’s House of Representatives approved a medical cannabis measure by a 61-57 vote to allow up to 66 dispensaries to open during their pilot program. Pennsylvania’s House Bill 1181 has been introduced and would allow patients with certain conditions to grow and use cannabis and paves the way for dispensaries, or “compassion centers” to distribute cannabis. Pennsylvania has also introduced a bill (SB 528) to legalize, tax, and regulate adult use of cannabis.
For more information on X-Change and its Phytiva brand, visit www.phytiva.com
Today before the opening bell, Rainbow Coral announced that it has opened talks this week to potentially partner with an emerging innovator in the transdermal delivery sector. This move is part of the company’s drive to carve out a share of the $142 billion U.S. drug delivery market.
Transdermal patches are an increasingly popular drug delivery system that is being developed for everything from contraception to Parkinson’s disease. Transdermal drug delivery prevents many of the problems associated with oral and intravenous routes as well as offers major advantages such as improved bioavailability, more uniform plasma levels, longer duration of action, reduced side effects, and improved therapy.
Some analysts have predicted that the transdermal delivery market could be worth as much as $31.5 billion by 2015 from a value of $21.5 billion just three years ago. Rainbow Coral believes partnering with an emerging leader in the sector could help the company capture a big piece of that growth.
“Transdermal patches offer a non-invasive option for treating many diseases and disorders,” said RBCC CEO Patrick Brown. “The appeal is obvious. We’re in negotiations now with a patch developer we believe has high profit potential, and we’re optimistic that a deal can be struck soon.”
For more information, visit www.RainbowBioSciences.com
VIASPACE CEO, Dr. Carl Kukkonen, has returned from Nicaragua after a series of business meetings, the company announced today. The visit resulted in a Joint Development Agreement with Grain Hill/AGRICORP for the creation of a new special purpose company to develop, build, own, and operate a 2,100 acre Giant King™ Grass plantation and a co-located 12 MW biomass power plant on the AGRICORP Agricola Miramontes plantation. Dr. Kukkonen and Grain Hill/AGRICORP CEO and Board President, Amilcar Ybarra-Rojas, signed the agreement.
AGRICORP is a subsidiary of Grain Hill, a diversified agro-industrial business group in the agricultural industry. It has revenues of $300 million per year with operations in Nicaragua, Costa Rica, and El Salvador.
“AGRICORP is a strong and highly respected company,” remarked Dr. Kukkonen. “I am confident that together we can rapidly bring this renewable, green energy project to Nicaragua. The key to successful financing and operation of a biomass power plant is having a reliable, low-cost source of biomass for the lifetime of the power plant. With our co-located Giant King Grass plantation, we will be growing our own fuel. Furthermore, AGRICORP is already growing and milling rice on the same plantation. The waste products are rice straw and rice husks and these can be burned in the same power plant. We will have the security of both fuel sources.”
VIASPACE Chairman, Dr. Kevin Schewe, added, “Our partnership with AGRICORP is an example of perfect timing. We are actively discussing similar Giant King Grass plantations co-located with power plant projects in several countries around the globe. We believe that our project with AGRICORP in Nicaragua will be an international model that can be scaled and replicated anywhere there is a suitable climate and growing conditions for Giant King Grass. This is the ideal project for VIASPACE because we will receive a license fee for Giant King Grass and also will be an equity partner in the power plant. This is the future and the growth path for our company.”
Dr. Kukkonen’s trip to Nicaragua was jam-packed with business related to this agreement. He and AGRICORP personnel met recently with government officials and private companies to get project development off the ground. This included obtaining all necessary governmental approvals and licenses, long-term power purchase agreements, debt and equity financing, and a contract with an Engineering Procurement and Construction (EPC) company to build the power plant.
Dr. Kukkonen also met with US Embassy Commercial, Energy and Agriculture officers in Managua, and obtained background information and advice on doing business in Nicaragua. He also met with PRONicaragua, an entity which facilitates foreign investment in the African nation.
According to the agreement, VIASPACE and AGRICORP will be equal shareholders and will lead the development of the plantation and power plant project. The companies will solicit debt and equity financing, and interested parties can access a brief description of the project on the VIASPACE website at www.VIASPACE.com.
The Guitammer Company, a provider of low frequency sound and creator of the award-winning line of ButtKicker®-brand low frequency audio transducers, has formed a promotional partnership with Warner Bros. Pictures and Legendary Pictures for this summer’s release, “Warner Bros. Pictures and Legendary Pictures Pacific Rim.”
“We couldn’t be more thrilled to work closely with the teams at Warner Bros. Pictures and Legendary Pictures on the Pacific Rim release,” Mark Luden, president of Guitammer stated in the press release. “By partnering with them, we expect to be able to reach millions of movie fans, and to communicate the ButtKicker product experience ‘feel what you’ve been missing.’”
The ButtKicker-brand low frequency audio transducers are designed to enhance cinematic experience by letting viewer feel the movie’s low-frequency sound (bass).
ButtKicker and Warner Bros. have teamed up three times in the past, for the movies “Sherlock Holmes,” “Clash of the Titans,” and “Sucker Punch,” to reach a target demographic of moviegoers between the ages of 18 –35 and 25 – 54.
Guitammer also announced that from June 14 to July 31, the company will launch an integrated online marketing campaign as well as a “SURFACE LIKE A KAIJU OR STRIKE LIKE A JAEGER” contest valued at approximately $4,500. Fans should visit www.thebuttkicker.com or www.facebook.com/thebuttkicker to enter to win.
For more information visit www.guitammer.com and www.thebuttkicker.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Announces 2013 Annual Meeting of Stockholders
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Announces Generx Publication In Molecular Therapy
- DoMark International, Inc. (DOMK) Announces Move to Protect Shareholders by Cancelling 50k Preferred Shares, 5.74M Common A Shares
- GNCC Capital, Inc. (GNCP) Reaches Agreement to Acquire White Hills Gold Properties
- GlobalWise Investments, Inc. (GWIV) Adds Toshiba Business Solutions AZ/CO as New Channel Sales Partner
- International Stem Cell Corp. (ISCO) to Present at Two Upcoming Investor Conferences
- Loans4Less.com, Inc. (LFLS) CEOCFO Magazine Interview Highlights Solid Market Position
- Low Carbon Technologies International, Inc. (LWCTF) Plans to Announce 6 Month YTD Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
- Solar Wind Energy Tower, Inc. (SWET) Partners with Commonwealth Dynamics, Inc.
- The Aristocrat Group Corp. (ASCC) Forecasts Big Growth This Summer
- The Guitammer Company Inc. (GTMM) Teams Up With Warner Bros. and Legendary Picturesfor Summer Release of "Pacific Rim," From Oscar®-Nominated Director, Guillermo del Toro
- VentriPoint Diagnostics Ltd. (VPTDF) Announces Private Placements
- Viaspace, Inc. (VSPC) and AGRICORP Sign Joint Development Agreement for 12 MW Power Plant Co-located with 2,100 acre Giant King Grass Plantation in Nicaragua
- VistaGen Therapeutics, Inc. (VSTA) and Duke University Publish Results on Production of Functional 3D Human Heart Tissue
- X-Change Corp. (XCHC) Issues Positive Market Update and Reinforces Existing Outlook Upon Seeing Momentum for Support and Industry Changes